MSK researchers found low levels of STING activation (orange) in ovarian cancers with high levels of whole-genome duplication (left) compared to those with low levels (right). This revealed how genome ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights ...

An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...

Ovarian cancer symptoms can be vague and ill-defined, leading to the creation of a catch-all acronym - BEAT. Dr. Thompson is ...

Dr. Claire Thompson, a Consultant Gynaecological Oncologist at the Mater Misericordiae University Hospital and Rotunda Hospital, explains the signs and symptoms of ovarian cancer ...

Ovarian cancer occurs when cancer cells start to form in the tissue of the ovaries, foundational organs of a woman's reproductive system. Its signs, such as bloating or tiredness, are easily ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without ...

Background: Ovarian cancer (OV) is a common malignancy in the female reproductive system, characterized by poor prognosis and high recurrence rates. The discovery of dependable molecular markers is ...

The unavailability of accurate and reliable methods for early ovarian cancer detection represents a major gap in ovarian cancer diagnosis and management. The emergence and recent integration of ...

Ovarian cancer is often called a “silent killer” because most people don’t know they have it until it has already spread to other parts of the body. In fact, about 75% of patients are ...

Ovarian cancer and treatments like surgery, chemotherapy, radiation, and targeted therapy can lead to a host of issues.